95
Views
2
CrossRef citations to date
0
Altmetric
Original Research

A Nomogram Based on Comorbidities and Infection Location to Predict 30 Days Mortality of Immunocompromised Patients in ICU: A Retrospective Cohort Study

ORCID Icon & ORCID Icon
Pages 10281-10292 | Published online: 24 Dec 2021

References

  • Soares M, Bozza FA, Angus DC, et al. Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study. Intensive Care Med. 2015;41(12):2149–2160. doi:10.1007/s00134-015-4076-7
  • Darmon M, Ranzani OT, Azoulay E. Focus on immunocompromised patients. Intensive Care Med. 2017;43(9):1415–1417. doi:10.1007/s00134-017-4857-2
  • Azoulay E, Soares M, Benoit D. Focus on immunocompromised patients. Intensive Care Med. 2016;42(3):463–465. doi:10.1007/s00134-016-4224-8
  • Barbier F, Mer M, Szychowiak P, et al. Management of HIV-infected patients in the intensive care unit. Intensive Care Med. 2020;46(2):329–342. doi:10.1007/s00134-020-05945-3
  • Morales-Tisnes T, Quintero-Ortiz L, Quintero-Munoz E, Sierra-Matamoros F, Arias-Aponte J, Rojas-Villarraga A. Prevalence of hospital readmissions and related factors in patients with autoimmune diseases. J Transl Autoimmun. 2021;4:100121. doi:10.1016/j.jtauto.2021.100121
  • Buchtele N, Lobmeyr E, Cserna J, et al. Prevalence and impact of vitamin D deficiency in critically ill cancer patients admitted to the intensive care unit. Nutrients. 2020;13(1):22. doi:10.3390/nu13010022
  • Ladha KS, Zhao K, Quraishi SA, et al. The Deyo-Charlson and Elixhauser-van Walraven Comorbidity Indices as predictors of mortality in critically ill patients. BMJ Open. 2015;5(9):e008990. doi:10.1136/bmjopen-2015-008990
  • Sharabiani MT, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50(12):1109–1118. doi:10.1097/MLR.0b013e31825f64d0
  • Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care. 2004;42(4):355–360.
  • Lieffers JR, Baracos VE, Winget M, Fassbender K. A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer. 2011;117(9):1957–1965. doi:10.1002/cncr.25653
  • Shin JH, Worni M, Castleberry AW, et al. The application of comorbidity indices to predict early postoperative outcomes after laparoscopic Roux-en-Y gastric bypass: a nationwide comparative analysis of over 70,000 cases. Obes Surg. 2013;23(5):638–649. doi:10.1007/s11695-012-0853-3
  • Austin SR, Wong YN, Uzzo RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the Charlson Comorbidity Index and Elixhauser Score Work. Med Care. 2015;53(9):e65–72. doi:10.1097/MLR.0b013e318297429c
  • Koulenti D, Vogelaers D, Blot S. What’s new in invasive pulmonary aspergillosis in the critically ill. Intensive Care Med. 2014;40(5):723–726. doi:10.1007/s00134-014-3254-3
  • Johnson AE, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3:160035. doi:10.1038/sdata.2016.35
  • Azoulay E, Lemiale V, Mokart D, et al. Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. JAMA. 2018;320(20):2099–2107. doi:10.1001/jama.2018.14282
  • Sheth M, Benedum CM, Celi LA, Mark RG, Markuzon N. The association between autoimmune disease and 30-day mortality among sepsis ICU patients: a cohort study. Crit Care. 2019;23(1):93. doi:10.1186/s13054-019-2357-1
  • Lu X, Wang X, Gao Y, et al. Efficacy and safety of corticosteroids for septic shock in immunocompromised patients: a cohort study from MIMIC. Am J Emerg Med. 2021;42:121–126. doi:10.1016/j.ajem.2020.02.002
  • Johnson AE, Stone DJ, Celi LA, Pollard TJ. The MIMIC code repository: enabling reproducibility in critical care research. J Am Med Inform Assoc. 2018;25(1):32–39. doi:10.1093/jamia/ocx084
  • Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.83
  • Peker N, Couto N, Sinha B, Rossen JW. Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approaches. Clin Microbiol Infect. 2018;24(9):944–955. doi:10.1016/j.cmi.2018.05.007
  • Marcoulides KM, Raykov T. Evaluation of variance inflation factors in regression models using latent variable modeling methods. Educ Psychol Meas. 2019;79(5):874–882. doi:10.1177/0013164418817803
  • Le Gall JR, Klar J, Lemeshow S, et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA. 1996;276(10):802–810. doi:10.1001/jama.1996.03540100046027
  • Van Den Berg HA. Occam’s razor: from Ockham’s via moderna to modern data science. Sci Prog. 2018;101(3):261–272. doi:10.3184/003685018X15295002645082
  • Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):374. doi:10.1186/s13054-019-2663-7
  • Mehta HB, Sura SD, Adhikari D, et al. Adapting the Elixhauser comorbidity index for cancer patients. Cancer. 2018;124(9):2018–2025. doi:10.1002/cncr.31269
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
  • Alp E, Damani N. Healthcare-associated infections in intensive care units: epidemiology and infection control in low-to-middle income countries. J Infect Dev Ctries. 2015;9(10):1040–1045. doi:10.3855/jidc.6832
  • Salzberger B, Hitzenbichler F, Hanses F. [Treatment of infections in the critically ill under immunosuppression: what must be considered?]. Z Rheumatol. 2019;78(10):940–946. German. doi:10.1007/s00393-019-00706-0
  • Florescu DF, Stohs EJ. Approach to infection and disease due to adenoviruses in solid organ transplantation. Curr Opin Infect Dis. 2019;32(4):300–306. doi:10.1097/QCO.0000000000000558
  • Zeng L, Ma Y. [Application of different death evaluation indicators for HIV/AIDS prevention and treatment]. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37(5):745–748. Chinese. doi:10.3760/cma.j.issn.0254-6450.2016.05.033
  • Rogers RL, Feller ED, Gottlieb SS. Acute congestive heart failure in the emergency department. Cardiol Clin. 2006;24(1):115–123, vii. doi:10.1016/j.ccl.2005.09.004
  • Halpin DMG, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(1):24–36. doi:10.1164/rccm.202009-3533SO
  • Ball S, Nugent K. Microparticles in hematological malignancies: role in coagulopathy and tumor pathogenesis. Am J Med Sci. 2018;355(3):207–214. doi:10.1016/j.amjms.2017.11.014
  • Wang H, Liu W, Tian M, et al. Coagulopathy associated with poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection. Biosci Trends. 2017;11(4):469–474. doi:10.5582/bst.2017.01080
  • Sabate A, Dalmau A, Koo M, Aparicio I, Costa M, Contreras L. Coagulopathy management in liver transplantation. Transplant Proc. 2012;44(6):1523–1525. doi:10.1016/j.transproceed.2012.05.004
  • Dhainaut JF, Shorr AF, Macias WL, et al. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med. 2005;33(2):341–348. doi:10.1097/01.CCM.0000153520.31562.48
  • Fang WF, Chen YM, Lin CY, et al. Immune profiles and clinical outcomes between sepsis patients with or without active cancer requiring admission to intensive care units. PLoS One. 2017;12(7):e0179749. doi:10.1371/journal.pone.0179749
  • Takeda K, Sawada Y, Kumamoto T, Tanaka K, Endo I. Severe sepsis after living donor liver transplantation: risk factors and outcomes. Transplant Proc. 2016;48(6):2124–2129. doi:10.1016/j.transproceed.2016.03.040
  • Rosenow EC, Wilson WR, Cockerill FR. Pulmonary disease in the immunocompromised host. 1. Mayo Clin Proc. 1985;60(7):473–487. doi:10.1016/S0025-6196(12)60872-6
  • Beck JM, Rosen MJ, Peavy HH. Pulmonary complications of HIV infection. Report of the fourth NHLBI workshop. Am J Respir Crit Care Med. 2001;164(11):2120–2126. doi:10.1164/ajrccm.164.11.2102047
  • Bajaj SK, Tombach B. Respiratory infections in immunocompromised patients: lung findings using chest computed tomography. Radiol Infect Dis. 2017;4(1):29–37. doi:10.1016/j.jrid.2016.11.001
  • Vazquez Guillamet C, Hsu JL, Dhillon G, Vazquez Guillamet R. Pulmonary infections in immunocompromised hosts: clinical. J Thorac Imaging. 2018;33(5):295–305. doi:10.1097/RTI.0000000000000351
  • De Carvalho Parahym AM, De Melo LR, De Morais VL, Neves RP. Candidiasis in pediatric patients with cancer interned in a university hospital. Braz J Microbiol. 2009;40(2):321–324. doi:10.1590/S1517-83822009000200020
  • Tandogdu Z, Cai T, Koves B, Wagenlehner F, Bjerklund-Johansen TE. Urinary tract infections in immunocompromised patients with diabetes, chronic kidney disease, and kidney transplant. Eur Urol Focus. 2016;2(4):394–399. doi:10.1016/j.euf.2016.08.006
  • Van de Louw A, Mirouse A, Peyrony O, Lemiale V, Azoulay E. Bacterial pneumonias in immunocompromised patients. Semin Respir Crit Care Med. 2019;40(4):498–507. doi:10.1055/s-0039-1696961
  • Ramirez JA, Musher DM, Evans SE, et al. Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies. Chest. 2020;158(5):1896–1911. doi:10.1016/j.chest.2020.05.598
  • Azoulay E, Russell L, Van de Louw A, et al. Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med. 2020;46(2):298–314. doi:10.1007/s00134-019-05906-5
  • McCreery RJ, Florescu DF, Kalil AC. Sepsis in immunocompromised patients without human immunodeficiency virus. J Infect Dis. 2020;222(Suppl 2):S156–S165. doi:10.1093/infdis/jiaa320
  • Florescu DF, Kalil AC. Cytomegalovirus infections in non-immunocompromised and immunocompromised patients in the intensive care unit. Infect Disord Drug Targets. 2011;11(4):354–364. doi:10.2174/187152611796504773
  • Geerlings SE, Mulvey MA, Stapleton AE, Klumpp DJ. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr. 2016;4(5). doi:10.1128/microbiolspec.UTI-0002-2012
  • Valentin A, Jordan B, Lang T, Hiesmayr M, Metnitz PG. Gender-related differences in intensive care: a multiple-center cohort study of therapeutic interventions and outcome in critically ill patients. Crit Care Med. 2003;31(7):1901–1907. doi:10.1097/01.CCM.0000069347.78151.50
  • Mahmood K, Eldeirawi K, Wahidi MM. Association of gender with outcomes in critically ill patients. Crit Care. 2012;16(3):R92. doi:10.1186/CC11355
  • Eslami MH, Rybin DV, Doros G, Siracuse JJ, Farber A. External validation of Vascular Study Group of New England risk predictive model of mortality after elective abdominal aorta aneurysm repair in the Vascular Quality Initiative and comparison against established models. J Vasc Surg. 2018;67(1):143–150. doi:10.1016/j.jvs.2017.05.087